<DOC>
	<DOCNO>NCT02072239</DOCNO>
	<brief_summary>The purpose study determine whether Angioshield device safely applied support saphenous vein graft use standard coronary bypass surgery .</brief_summary>
	<brief_title>Angioshield First-In-Human Study Demonstrate Preliminary Safety Efficacy</brief_title>
	<detailed_description>\This first human study intend determine large pivotal study justify .</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<criteria>Subject eligible inclusion investigation he/she : age 18 80 year age , inclusive require Coronary Atery Bypass Graft ( CABG ) surgery minimum one SVG use bypass stenosis Right Coronary , Circumflex , Diagonal , Obtuse Marginal artery , due atherosclerotic coronary artery disease able give inform write consent willing able complete followup visit procedure Subject exclude participation investigation he/she : currently enrol another clinical investigation unable tolerate comply require postsurgical medication image ( e.g. , anticoagulation regimen ; know allergy contrast agent ) may pregnant lactating , plan become pregnant next 12 month show presence hypercoagulable state history idiopathic venous arterial thrombosis acute MI within last 21 day previous CABG require emergency surgery leave ejection fraction ( LEF ) less 20 % target vessel stenosis le 70 % transmural infarct target artery territory currently require dialysis concomitantsurgery kind varicose vein previous saphenectomy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>CABG</keyword>
	<keyword>Intimal Hyperplasia</keyword>
	<keyword>Atherosclerosis</keyword>
	<keyword>Myocardial Infarction</keyword>
</DOC>